![How Social Platforms Measure Video Views [Infographic]](https://imgproxy.divecdn.com/AncxHXS242CT-kDlEkGZi7uQ2k70-ebTAh7Lm14QKb8/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9ob3dfcGxhdGZvcm1zX21lYXN1cmVfdmlld3MucG5n.webp)
![How Google’s AI Mode Compares to Traditional Search and Other LLMs [AI Mode Study]](https://static.semrush.com/blog/uploads/media/86/bc/86bc4d96d5a34c3f6b460a21004c39e2/f673b8608d38f1e4be0316c4621f2df0/how-google-s-ai-mode-compares-to-traditional-search-and-other-llms-ai-mode-study-sm.png)
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know
On April 29, Novo Nordisk (NYSE: NVO) and Hims & Hers Health (NYSE: HIMS) announced they were collaborating to allow Hims & Hers to sell the weight-loss drug Wegovy. Hims & Hers stock soared on the news. It wasn't a marriage made in heaven. Novo Nordisk revealed on Monday that it will no longer work with Hims & Hers, and that direct access to Wegovy won't be available via NovoCare Pharmacy to Hims & Hers members.Here's what investors need to know about the implications of the termination of the short-lived deal between these two healthcare companies. Continue reading
On April 29, Novo Nordisk (NYSE: NVO) and Hims & Hers Health (NYSE: HIMS) announced they were collaborating to allow Hims & Hers to sell the weight-loss drug Wegovy. Hims & Hers stock soared on the news.
It wasn't a marriage made in heaven. Novo Nordisk revealed on Monday that it will no longer work with Hims & Hers, and that direct access to Wegovy won't be available via NovoCare Pharmacy to Hims & Hers members.
Here's what investors need to know about the implications of the termination of the short-lived deal between these two healthcare companies.
